Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

NCT06869551

RecruitingPhase 3

Sponsor: Bristol-Myers Squibb

Conditions: Juvenile Psoriatic Arthritis

Interventions: Deucravacitinib, Placebo

Countries: United States, Brazil, Bulgaria, China, Czechia, Germany, Italy, Puerto Rico

The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.

Eligibility overview

Sex: ALL

Age: 5 Years to 17 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria

* Participants must have been diagnosed with Juvenile Psoriatic Arthritis (JPsA).
* Participants must have at least three joints that are affected by arthritis.
* Participants must have tried at least one type of medicine for JPsA for at least three months, but it didn't work well or caused problems.

Exclusion Criteria

* Participants must not have been diagnosed with JPsA before 5 years of age.
* Participants must not have other types of Juvenile Idiopathic Arthritis (JIA) that aren't JPsA,
* Participants must not have a history of chronic eye inflammation (uveitis), or were diagnosed with uveitis within the last three months.
* Other protocol-defined Inclusion/Exclusion criteria apply.
Locations (47)
  • Lancaster, California, United States
  • Chicago, Illinois, United States
  • Indianapolis, Indiana, United States
  • North New Hyde Park, New York, United States
  • Cincinnati, Ohio, United States
  • Cleveland, Ohio, United States
  • Austin, Texas, United States
  • Fortaleza, Ceará, Brazil
  • Cuiabá, Mato Grosso, Brazil
  • Belo Horizonte, Minas Gerais, Brazil
  • Curitiba, Paraná, Brazil
  • Curitiba, Paraná, Brazil
  • Recife, Pernambuco, Brazil
  • Porto Alegre, Rio Grande do Sul, Brazil
  • Porto Alegre, Rio Grande do Sul, Brazil
  • Vila Clementino, São Paulo-SP, Brazil
  • Rio de Janeiro, Brazil
  • São Paulo, Brazil
  • São Paulo, Brazil
  • Plovdiv, Bulgaria
  • Sofia, Bulgaria
  • Sofia, Bulgaria
  • Beijing, Beijing Municipality, China
  • Beijing, Beijing Municipality, China
  • Chongqing, Chongqing Municipality, China
  • Guangzhou, Guangdong, China
  • Nanjing, Jiangsu, China
  • Changchun, Jilin, China
  • Hangzhou, Zhejiang, China
  • Shanghai, China
  • + 17 more on CT.gov